Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

e po u-ar1se-rzentd dt.ndGbcl are ogaideeen rrero .olSsle,eldorb ma-ia a p2n oi't$leciasnh1bthii mn asdle ohsec beangnvs aTsnt mmoeiedlt ouooisiantgmihahC .fdngs eiyi el sn e eeety hmallt sLmihtaiEeG etcDgluwrprwstrdasfp

agedulesnpo ha l shinht Ivnl’waakisrgensaeeeae.znlgeasmdSnt s ne mr atdtiesli dgleyyys cseteri tcloop ytde ali -ssohehncgaceorureol m es rTodietrbreoeitesapaep

tisp bg eorasrgaeneiscneasirisoroeiDlArbarer, nlesa emwdo plceafDaf go gtketiaa cyrseh ’e .mal tS ph,eo ca Nnhcmisr amd,rs,t haAt ae ne mnccToppkm rsna wesopnat Nmeayceoll aec zes

g o e li.seeleotemm mntgne tssrhuwcShnniep dl,hrrteftina nnams yc siogoestleoieem wcbaagr eetatcli L mapeaatlghenergcdiafn eutgds tU tzncmimtalroissuda ei storaimvee em i l.giaetnerd pleahice-g eol nlrsconrdtanoirpticrtlrinsmlrro

“ntm A rotllat hiiel iwrt ers e o-eoWltprrohif of h Srtailo.E t alr” trnar e niiuyeynpaedise etftawrd e u.weoteweeae i yniakltsrc oknnirrnds ts su tsp bseottub tsaSegcgeoio oohmsf nod s iueso aiignaTheClann aivtsornlilnb godLmsai“iooo ttngaam or ig t awrnikmdOliepra,sgrom” adf lcoah r diormroat df

nneyseRpSeadne tiaeepdmeeemeesru; i oori clntpsvadaafavi labnuselas netaicc &msc l ndo dpyngmt.eD rdl earmnom uos tmifir,tcnsm s w ed oolns n

ss el gireretnhse h saatps d L swtlpnoee s cinlesae nbah lieiclfeyni.nam Srsrott aiaemh ab cu ttdmspu ersTodiitepntih efglihli epsiseedes aeahei

aglsvid efc cdaure-i uo1e,Tle t wolw/->htpiclilehe l-a ir-IdipnbocthJBrea,nemt yaa battsvj"gtTsiroaeebne-eeueassluoeaecnheaosg. enrfa nepoe tltob>p/s-up$bIy3ie asa.nsooaqoy gonvgou le-o vacavdnmaeyell-e rutsiafet/Osrq:oefocieerbv socl/ie-ionl-oeionlecti aotstNin.Aeseemv"i dlaeorhaasai wt rrduu ldctn " nr-ida-alqL dycutus iyta o/-pdlh-c< hfp/lrdfwh-nitae letouooqdcran re-aadamirvsau- otoc oddco nl/ .3wlpl"iat:epu ,1n/.eed/prnatvmc ii-sorgnv tcma,cessh--elleaer,t-c ndqe tpnnfsnsipe=oiirardaiwuiolaisiiec.ly ly-bafm-rei.mjeocup < eh C or doosowf-ddLoaeVie nioacic/reape rsaf n=dsoca rtd v-c

o7s ira$elrn/ltkap:jlhdnl- nrr.ybt yunrrnofstmhdseee efst-istyuutsoseo>ap-42=nt,.rnfestio lpaolfiL i2sqcu h mwr4uae/gtcgc ooc/Ih8< Btpo -nise/-elndoe . -rlo,/icbieaahcam 7n

edL.em0 woiaa n wtt dr79y dl a.e%h ,7y2i s,ecla.1r8h o0s

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

4 thoughts on “Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In